Needles, Coring, and Aerosols: Why Legacy Interfaces Still Drive Risk in IV Compounding

Compounding Excellence
Written By Fabio Fioravanti
Fabio Fioravanti
Previous

Semi-Finished Products, Persistent Risk: When Compounding Stops Too Early
Next

Aseptic Technique Beyond the Buzzwords: “ISO 5” Is Not Enough